News

Add articles to your saved list and come back to them any time. Medical innovator Proteomics International Laboratories is charging into selling mode after locking away $4.5 million from ...
Add articles to your saved list and come back to them any time. Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has picked up an Australian patent for its finger-prick ...
Data-independent acquisition mass spectrometry (DIA-MS) has emerged as a key technology in quantitative proteomics. Here, the authors introduce DIA-BERT, a transformer model pre-trained on ...
Ben is a mass spectrometrist whose work revolves around establishing single-cell proteomics (SCP) as a robust and approachable toolbox for exploring a broad range of pathology- and ...
There is a broad consensus that proteomics will play a central role in driving the future of drug development and biomarker discovery. However, despite its potential, proteomics has yet to become ...
First author Florian Rosenberger, from the Department of Proteomics and Signal Transduction, explains: “In the homozygous form, something striking stands out. It is a monogenetic disease, meaning all ...
A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with the promise of delivering a "transformation" in the study of diseases and ...
Proteins are the molecular building blocks and engines of the cell, and are involved in practically all life processes. Researchers at the Max Planck Institute of Biochemistry investigate the ...
Spatial proteomics offers unprecedented insights into the localization, quantity, and interactions of proteins within cells and tissues, thereby enabling researchers and clinicians to map protein ...
Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...
These are challenging tasks in proteomics requiring high-throughput analysis of hundreds of samples for just a single drug-to-proteome system. In this work, we performed these analyses for ...